Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.

Signaling pathways perturbing muscle mass.

Glass, David J · 2010 · Current Opinion in Clinical Nutrition and Metabolic Care

Abstract

Purpose of review To discuss the mechanisms of muscle loss during cachexia. Recent findings Cachexia can be defined as a wasting of lean body mass that cannot be reversed nutrionally, indicating a dysregulation in the pathways maintaining body composition. In skeletal muscle, during cachexia, there is an upregulation of protein degradation. A search for transcriptional markers of muscle atrophy led to the discovery of the E3 ubiquitin ligases MuRF1 and MAFbx (also called Atrogin-1). These genes are upregulated in multiple models of atrophy and cachexia. They target particular protein substrates for degradation via the ubiquitin/proteasome pathway. The insulin-like growth factor-1 can block the transcriptional upregulation of MuRF1 and MAFbx via the phosphatidylinositol-3 kinase/Akt/Foxo pathway. MuRF1's substrates include several components of the sarcomeric thick filament, including myosin heavy chain. Thus, by blocking MuRF1, insulin-like growth factor-1 prevents the breakdown of the thick filament, particularly myosin heavy chain, which is asymmetrically lost in settings of cortisol-linked skeletal muscle atrophy. Insulin-like growth factor-1/phosphatidylinositol-3 kinase/Akt signaling also dominantly inhibits the effects of myostatin, which is a member of the transforming growth factor-[beta] family of proteins. Deletion or inhibition of myostatin causes a significant increase in skeletal muscle size. Recently, myostatin has been shown to act both by inhibiting gene activ…

Overview

Integrity signals

Registry

Crossref · 10.1097/mco.0b013e32833862df

Cites

56 of 56 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 56 references

Research works printed but not linked: 1

  1. Stitt, 2004, Mol Cell, 14, 395, 10.1016/S1097-2765(04)00211-4 · DOI · Paper page

Cited by

See all 359

Metadata

Authors
Glass, D. J.
Corresponding author
Glass, David J
Venue
Current Opinion in Clinical Nutrition and Metabolic Care
Published
2010-05
Volume
13
Issue
3
Pages
225-229
ISSN
1363-1950 (ISSN-L)
OpenAlex
W2078192607
Cited by
359
References
56
Citations by year
2026: 4 · 2025: 9 · 2024: 17 · 2023: 9 · 2022: 17 · 2021: 13 · 2020: 15 · 2019: 14 · 2018: 25 · 2017: 20 · 2016: 13 · 2015: 30 · 2014: 28 · 2013: 45 · 2012: 55
FWCI
4.06
Type
journal article
Language
en
Open access
closed
Locations
  • Current Opinion in Clinical Nutrition & Metabolic Care (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
  • Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
  • Health Sciences › Nursing › Nutrition and Dietetics › Muscle metabolism and nutrition
Keywords
cachexia, skeletal muscle atrophy, muscle mass loss, MuRF1, atrogin-1, ubiquitin-proteasome system, protein degradation, insulin-like growth factor I, phosphatidylinositol 3-kinase/Akt signaling, FOXO, myostatin, TGF-beta, myosin heavy chain, cortisol, lean body mass
MeSH terms
Forkhead Box Protein O1, Cachexia, Gene Expression Regulation, Hydrocortisone, Muscle Proteins, Muscular Atrophy, Organ Size, Signal Transduction, Transforming Growth Factor beta, Muscle, Skeletal, Myosin Heavy Chains, Phosphatidylinositol 3-Kinases, Ubiquitin-Protein Ligases, Proto-Oncogene Proteins c-akt, Forkhead Transcription Factors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Signaling pathways perturbing muscle mass. https://app.cochat.ai/papers/10.1097/mco.0b013e32833862df
The paper
Glass, D. J. (2010). Signaling pathways perturbing muscle mass. Current Opinion in Clinical Nutrition and Metabolic Care. https://doi.org/10.1097/mco.0b013e32833862df

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.